SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as investors focus on potential catalyst opportunities involving GLP-1 and peptide distribution, despite ongoing debates about the stock's volatility and recent C-suite share sales. The community remains heavily divided, with bulls highlighting long-term platform growth and market share gains, while bears continue to scrutinize the high short interest and technical pressure.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple is trending as investors react to a flurry of reports regarding real-world adoption, including integration with major payment platforms and potential legislative breakthroughs with the Clarity Act. While the community is actively debating the coin's utility-driven long-term potential versus concerns over supply dilution, sentiment remains polarized between those accumulating at current levels and those frustrated by its sideways price action.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors monitor record-high short interest and anticipation surrounding the Northern Data acquisition, which is expected to significantly boost the company's cloud and AI infrastructure capacity. The community is focused on the strategic financial commitment from Tether and the potential for a substantial short squeeze as traders weigh the company's long-term growth prospects against ongoing market volatility.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending following the announcement of a DARPA contract and a successful photonic interconnect milestone that demonstrates the feasibility of networked quantum systems. Investors and community members are actively debating the company's long-term potential as a quantum infrastructure leader versus concerns over its current path to profitability and high volatility.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is facing significant pressure as investors express frustration over its persistent underperformance relative to broader market indices and a perceived lack of clear investment direction under new leadership. The stock is currently being scrutinized for its massive cash pile and limited deployment in growth sectors, leading to a polarized community debate between those holding for long-term defensive stability and those aggressively shorting the stock due to its inability to capture market rallies.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is generating significant social media buzz as traders debate its speculative recovery potential amid broader volatility in the quantum computing sector. While bullish sentiment is fueled by the company's established commercial annealing platform and strategic defense collaborations, bears are pointing to the stock's lack of consistent profitability and intensifying competition from gate-model advancements as reasons for caution.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is trending as investors closely monitor how geopolitical tensions in the Middle East and energy supply constraints could impact its critical role as the backbone of the global AI chip supply chain. Despite these risks, the community remains heavily focused on bullish call flow and strong fundamental demand for advanced nodes, viewing current market volatility as a potential entry point for long-term exposure to the AI infrastructure supercycle.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Xanadu Quantum Technologies is experiencing significant volatility and high investor attention following its recent debut as a publicly traded pure-play photonic quantum computing company. While some members of the community are betting on the company's long-term potential and strategic partnerships, others are actively debating its high burn rate and questioning whether the current price action is a momentum-driven squeeze or an unsustainable pump.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. is seeing significant retail attention as investors bet on the companys Bitcoin treasury strategy and the potential of its new digital credit assets, like SATA, amidst a broader recovery in Bitcoin. Community discourse is highly polarized, with vocal bulls highlighting accumulation opportunities and long-term price potential, while skeptical voices raise concerns over historical dilution, reverse splits, and managements Bitcoin acquisition costs.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is rallying sharply as market participants react to the SEC's move to eliminate the long-standing pattern day trading restriction, which is expected to drive higher trading volumes and engagement. Investors are also buoyed by the company's termination of a debt-linked agreement, leading to community discussions about a potential short squeeze and a long-term recovery toward double-digit valuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Healthcare Stocks To Watch Today - April 14th

Johnson & Johnson, UnitedHealth Group, Intuitive Surgical, Medtronic, Tempus AI, Hims & Hers Health, and Becton, Dickinson and Company are the seven Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies involved in...

Hims & Hers Powers Patient-Provider Connectivity via Digital Platforms

HIMS unites telehealth, records and pharmacy fulfillment on one digital platform, adding AI tools, diagnostics and FDA-approved medicines.

Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.

Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026

Hims & Hers Health, Inc. (Hims & Hers, NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2026 financial results after the market closes on...

Hims & Hers Health (NYSE:HIMS) Stock Price Up 9.1% - Here's What Happened

Hims & Hers Health (NYSE:HIMS) Trading 9.1% Higher - Here's What Happened...

Hims & Hers Health, Inc. $HIMS Shares Sold by Carnegie Investment Counsel

Carnegie Investment Counsel lowered its position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 69.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 93,334 shares of the company's stock after selling 210,575 shar...

Hims & Hers Health (NYSE:HIMS) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Hims & Hers Health from a "sell" rating to a "hold" rating in a report on Saturday...

Healthcare Stocks To Watch Now - April 8th

UnitedHealth Group, Johnson & Johnson, Intuitive Surgical, Medtronic, McKesson, Novartis, and Hims & Hers Health are the seven Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of companies that operate within the healthcare sectorincludi...

Hims & Hers Analyst Cuts Price Target On Downside Risk To 2026 Estimates

Downside risk for Hims & Hers Health's 2026 EBITDA estimates, as GLP-1 contribution expected to decline 50%. Neutral rating, PT cut to $21.read more...

<ul class="summary-bullets"><li>The CEO said Hims shipped its first Novo Nordisk medicines nearly two weeks ago.</li><li>As part of the Novo deal, patients gained access to multiple Wegovy injection and pill dose options.</li><li>Dudum’s outlook comes after CFO Yemi Okupe recently disclosed plans to sell shares under a Rule 10b5-1 trading plan.</li></ul>Shares of Hims &amp; Hers Health Inc. (HIMS) jumped 7% in premarket trading on Wednesday after CEO Andrew Dudum said the telehealth firm is on track to deliver over 100,000 Wegovy prescriptions per month following its truce with Novo Nordisk.<a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> slid over 4% on Tuesday, but gained over 6% in extended trading.&nbsp;<h2 class="st-heading-2">HIMS Targets 100K Wegovy Monthly Prescriptions</h2>Dudum&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/AndrewDudum/status/2041597399148458242">said on X</a> that the company shipped its first Novo Nordisk medicines nearly two weeks ago as part of a “strategic shift” in its weight-loss business and is already tracking toward a run rate of over 100,000 Wegovy prescriptions each month. “More treatment options mean more customers can find what works best for them,” Dudum said.The update comes after Novo dropped its patent-infringement lawsuit tied to Hims &amp; Hers’ earlier compounded GLP-1 offerings and instead reached an arrangement allowing the drugmaker to transition patients toward U.S. Food and Drug Administration (FDA) approved treatments.Under the deal, Hims &amp; Hers said it will discontinue marketing compounded GLP-1 alternatives and instead offer branded Wegovy alongside Ozempic for patients with Type 2 diabetes.Eligible patients will have access to multiple Wegovy injection doses ranging from 0.25 milligrams to 2.4 milligrams, along with pill-based formulations across several doses. Ozempic injection pens will also be available in doses ranging from 0.25 milligrams to 2 milligrams for diabetes management.Dudum’s comments reinforce confidence in the company’s outlook after CFO Yemi Okupe recently disclosed&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-hims-stock-slipping-premarket-today/cZJJZ9XRIpE">plans to sell</a> up to 240,560 shares worth about $4.89 million under a pre-arranged Rule 10b5-1 trading plan, as Hims &amp; Hers ramps its Novo Nordisk-backed GLP-1 rollout.&nbsp;<h2 class="st-heading-2">HIMS Gets Boost From Novo Deal And Peptides Optimism</h2>The update comes amid rising optimism around Hims as FDA officials are&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/hims-stock-gains-fda-lift-restrictions-on-peptides/cZEPCKRRIVZ">reportedly&nbsp;</a>moving to allow compounding pharmacies to manufacture more than a dozen injectable peptides that were restricted in 2023 over potential safety risks.Last month, Barclays raised its price target on the stock to $29 from $25 and maintained an ‘Overweight’ rating, saying the Novo Nordisk deal removes a key legal uncertainty and reflects expanding opportunity tied to new product launches. Needham also said that the market may still be “underappreciating” demand potential from cash-pay access to Wegovy pill formulations.<h2 class="st-heading-2">How Do Retail Traders Feel About HIMS?</h2>On Stocktwits, retail sentiment for HIMS slipped to ‘bearish’ over the past week from ‘bullish’ levels a month ago amid ‘extremely low’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/hims_ss_png_c15e7ee599.webp" alt="hims ss.png" width="973" height="145"><figcaption>HIMS sentiment and message volume as of April 8 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/AlphaEdge1/message/649670543">said</a> HIMS is “significantly undervalued with some estimates placing its intrinsic value as much as 66% to 75% higher than current trading levels. New highs in 2026 now possible”<stembedurl>https://stocktwits.com/AlphaEdge1/message/649670543</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/ClarissaLove/message/649668470">said</a>, “There’s really no bear case here anymore. Literally none.”<stembedurl>https://stocktwits.com/ClarissaLove/message/649668470</stembedurl>Over the past year, HIMS stock has declined nearly 30%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nbis-stock-on-hot-streak-amid-iran-volatility/cZJOFBhRIq0">Nebius Stock On Hottest Streak In Nearly A Month, Retail Sentiment Climbs Amid Iran Volatility</a>

In this photo illustration, a smartphone displays the logo of Hims & Hers Health in front of a screen showing the company's stock market chart. (Photo illustration by Cheng Xin/Getty Images)

HIMS Stock Jumps Premarket: CEO Targets 100K Monthly Wegovy Push After Novo Nordisk Truce

The development follows Novo Nordisk’s decision to drop its patent-infringement lawsuit tied to compounded GLP-1 offerings previously marketed by Hims.

Equity

Technology – AI, chips, software, cloud

Healthcare – Pharma, biotech, medical devices

Financials – Banks, payments, fintech

Energy – Oil, gas, renewables, uranium

Which sector are you most interested in deploying capital into right now?

Stocktwits

Stocktwits Polls

Traders are closely monitoring massive short interest levels as a potential catalyst for an explosive upward rally.

Investor sentiment is surging due to anticipation surrounding potential FDA regulatory updates and expansion into peptide therapies.

Bullish investors are setting aggressive technical price targets, with many eyeing the $30-$50 range as the next key milestones.

Persistent speculation regarding potential high-profile corporate buyouts and strategic partnerships is fueling intense debate.

HIMS
Hims & Hers Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HIMS News

HIMSHims & Hers Health Inc